TCT 1257: Residual Lipid-Rich Plaque Features Identified by IVUS-NIRS in NSTE-ACS Patients

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - InfraredX; B. Braun</li></ul>